These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3778209)

  • 1. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
    Wong JH; Gupta RK; Morton DL
    Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay.
    Gupta RK; Leitch AM; Morton DL
    Clin Exp Immunol; 1983 Sep; 53(3):589-99. PubMed ID: 6193912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in human malignant melanoma.
    D'Amelio R; Cooke B; Hobbs JR
    Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiologic characterization.
    Gupta RK; Morton DL
    J Natl Cancer Inst; 1984 Jan; 72(1):75-82. PubMed ID: 6582305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a well-characterized tumor-associated antigen on melanoma cell surface.
    Wong JH; Gupta RK; Morton DL
    J Surg Oncol; 1988 Jul; 38(3):147-50. PubMed ID: 3292843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance and nature of circulating immune complexes in melanoma patients.
    Gupta RK; Morton DL
    Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical relevance of immune complexes, associated antigen, and antibody in cancer.
    Salinas FA; Wee KH; Silver HK
    Contemp Top Immunobiol; 1985; 15():55-109. PubMed ID: 3896644
    [No Abstract]   [Full Text] [Related]  

  • 8. Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.
    Gupta RK; Leitch AM; Morton DL
    Cancer Immunol Immunother; 1983; 16(1):40-7. PubMed ID: 6556950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. I. Purification and development of a radioimmunoassay.
    Gupta RK; Morton DL
    J Natl Cancer Inst; 1984 Jan; 72(1):67-74. PubMed ID: 6582304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies and antigen expression in human melanoma detected by the immune adherence test.
    Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P
    Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine.
    Euhus DM; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1989; 29(4):247-54. PubMed ID: 2752392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in malignant melanoma: serial studies in 130 patients.
    Bharwani N; Campbell L; Ashley P; Queen WD; Phillips TM; Jerry LM
    Oncology; 1986; 43(3):143-8. PubMed ID: 3703459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen.
    Stuhlmiller GM; Darrow TL; Haupt DM; Seigler HF
    Cancer Immunol Immunother; 1987; 25(3):193-200. PubMed ID: 3677123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and pathogenetic implications of immune complexes in human cancer.
    Salinas FA; Wee KH
    Adv Immun Cancer Ther; 1986; 2():189-209. PubMed ID: 2962476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes in human melanoma: a consequence of deranged immune regulation.
    Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
    Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in malignant melanoma.
    Gupta RK
    Dis Markers; 1988 Jun; 6(2):81-95. PubMed ID: 3042263
    [No Abstract]   [Full Text] [Related]  

  • 17. Pilot studies using melanoma tumor-associated antigens (TAA) in specific-active immunochemotherapy of malignant melanoma.
    Hollinshead A; Arlen M; Yonemoto R; Cohen M; Tanner K; Kundin WD; Scherrer J
    Cancer; 1982 Apr; 49(7):1387-404. PubMed ID: 7059953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. III. Physicochemical properties.
    Gupta RK; Morton DL
    J Natl Cancer Inst; 1984 Jan; 72(1):83-92. PubMed ID: 6582306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay.
    Euhus DM; Gupta RK; Morton DL
    J Clin Lab Anal; 1989; 3(3):184-90. PubMed ID: 2754533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
    Wong JH; Aguero B; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.